Abstract: Compound K, a major metabolite of ginsenosides Rb1, which is produced by human intestinal bacteria after oral administration, is one of the main pharmacologic compounds found in ginseng. In our previous study, we demonstrated that compound K inhibited the production of nitric oxide (NO) and prostaglandin E2 in lipopolysaccharide (LPS)-treated RAW264.7 cells. However, the mechanisms by which compound K may be effective against inflammation remain unknown. In the present study, compound K significantly inhibited LPS-induced NO production by suppression of inducible NO synthase (iNOS) in LPS-treated RAW264.7 cells. Compound K also inhibited LPS-induced cyclooxygenase-2 (COX-2) expression at both the mRNA and protein levels. It effectively suppressed both the release and mRNA expression levels of pro-inflammatory cytokines such as interleukin-1β (IL-1β) and IL-6. The anti-inflammatory effects of compound K appeared to occur via inhibition of LPS-induced phosphorylation of mitogen-activated protein kinases (MAPKs) and inhibition of NF-κB translocation from the cytosol to the nucleus by suppressing phosphorylation of inhibitory kappa B-α (IκB-α). Furthermore, we showed that compound K inhibited LPS-induced NO generation in an experimental zebrafish model. Considering these results, compound K could potentially be developed as a natural anti-inflammatory agent.
Introduction
Although inflammation is a defense response against harmful stimuli and injury, its continued reaction is associated with the development of chronic diseases such as obesity, inflammatory bowel disease, and several cancers [1] [2] [3] . Macrophage activation plays a key role in the progression of multiple inflammatory diseases by secreting pro-inflammatory cytokines (e.g., interleukin (IL)-6 and IL-1β) that recruit additional immune cells to the site of infection or tissue injury, releasing cytotoxic and inflammatory molecules (e.g., nitric oxide (NO)), and critical enzymes (e.g., inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2)) [4, 5] . In particular, lipopolysaccharides (LPS)-stimulated macrophages are mediated through the trans-membrane signaling receptor toll-like receptor 4 (TLR4). Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), a pivotal regulator in TLR4
Nitric Oxide Determination
Raw 264.7 cells (1 × 10 4 per well) were plated in 96-well plates. Raw 264.7 cells were treated with various concentrations of compound K and then incubated with or without LPS (1 µg/mL) for 24 h. Nitrites released into the culture media were determined using the Griess reaction and presumed to reflect the NO levels. Aliquots of cell culture supernatant (100 µL) were mixed with 100 µL Griess reagent and incubated at room temperature for 15 min. The absorbance was then measured at 540 nm using an ELISA reader. Nitric oxide levels in sample were determined using a standard sodium nitrite curve.
Enzyme-Linked Immunosorbent Assays
Raw 264.7 cells were pretreated with compound K for 1 h and then stimulated with LPS (1 µg/mL) for 24 h. Levels of IL-1β and IL-6 in the culture media were quantified using EIA kits (BioLegend, San Diego, CA, USA) according to the manufacturer's instructions.
RNA Isolation and Reverse-Transcription Polymerase Chain Reaction
Total RNA was extracted using TRIzol ® reagent (Invitrogen, Carlsbad, CA, USA) according to manufacturer's method for reverse transcription polymerase chain reaction (RT-PCR) analysis. Total RNA (1 µg) was used reverse transcribed to cDNA using the Maxime RT PreMix kit (Intron, Seongnam, Korea). Amplification of the target genes was performed using specific oligonucleotide primers in a normal PCR system. The primers used were as follows: iNOS, forward (5 -CCCTTCCGAAGTTTCTGGCAGCAG-3 ), reverse (5 -GGCTGTCAGAGCCTCGTGGCTTTG-3 ); COX-2, forward (5 -ATGCTCCTGCTTGAG TATGT-3 ), reverse (5 -CACTACATCCTGACCCACTT-3 ); IL-6, forward (5'-CCATCTCTCCGTCT CTCACC-3 ), reverse (5 -AGACCGCTGCCTGTCTAAAA-3 ); IL-1β, forward (5 --3 ), reverse (5 -CTCTGCACACTCAAACTCCAC-3 ); GAPDH, forward (5 -AACTTTGGCATTGTGGAAGG-3 ), reverse (5 -ACACATTGGGGGTAGGAACA-3 ). The PCR products were subjected to electrophoresis on 1.0% agarose gels, which were stained with ethidium bromide and photographed.
Western Blot Analysis
Raw 264.7 cells were washed with PBS buffer, lysed with lysis buffer, and then centrifuged to remove cell debris. The protein concentration of the supernatant was determined using the Bradford assay. Protein extracts (50 µg) were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis(SDS-PAGE) and transferred to polyvinylidene difluoride membranes. The membranes were blocked and then immunoblotted with primary antibodies specific for iNOS, COX-2, p65, p-IκB-α, IκB-α, p-ERK, ERK, p-p38, p38, p-JNK, JNK, and GAPDH at 4 • C overnight. Secondary antibodies conjugated to horseradish peroxidase (1:1000) were then incubated with the blot for 1 h. The bands were visualized by enhanced chemiluminescence (ECL), and the protein bands were detected using LAS image software (Fuji, New York, NY, USA).
Zebrafish Care and Experimental Protocol
We performed the experiments like our previous paper [25] . All zebrafish experiments were approved by the Internal Animal Ethics Committee at CHA University (IACUC140001). Embryos of zebrafish (Danio rerio) were obtained from Chungnam National University (Daejeon, South Korea) as a gift. Synchronized zebrafish embryos were collected and re-arranged using a pipet at 20 embryos/well in six-well plates containing 2 mL of egg water. After 7−9 h post fertilization (hours post-fertilization; hpf), embryos were incubated with or without 40 µM concentrations of Compound K for 1 h. Zebrafish were stimulated by LPS (5 µg/mL) for 24 h at 28.5 • C. The zebrafish embryos were then transferred into fresh embryo medium.
Nitric Oxide Determination in Zebrafish
NO levels in the inflammatory zebrafish model were measured using a fluorescent probe dye, diaminofluorophore 4-amino-5-methylanino-2,7-difluoro-fluoroescein diacetate (DAF-FM DA) [26] [27] [28] . The transformation of DAF-FM DA by NO generates highly fluorescent triazole derivatives. Following stimulation by LPS, the zebrafish larvae were transferred into 96-well plates and treated with DAF-FM DA solution (1 µM) for 1 h in the dark at 28.5 • C. After incubation, the zebrafish larvae were rinsed in fresh zebrafish embryo medium and anesthetized with tricaine methanesulfonate solution before observation. The fluorescence intensity of individual zebrafish larvae was quantified using an ECLIPSE E600 (Nikon, Tokyo, Japan). The fluorescence was analyzed by Image J.
Statistical Analysis
All experiments were performed in triplicate. The data were statistically analyzed using a one-way analysis of variance (ANOVA) and Duncan's multiple range tests. All values are presented as the means ± standard deviation (SD) values. p-values in the multiple comparison results (e.g., a, b, c, and d) indicate significant differences among the groups; p < 0.05. Figure 1A shows the chemical structure of Compound K. To evaluate the cytotoxicity of compound K, RAW 264.7 cells were treated with various concentrations of compound K, under concentrations in previous study related with inflammation [18] , and then cell viability was determined using XTT assay. Compound K at concentrations up to 40 µM did not significantly affect RAW264.7 cell viability ( Figure 1B ). It was confirmed by observing cell morphology under a microscope (data not shown). Accordingly, all of the following experiments were performed within this range of compound K concentrations (20, 30 , and 40 µM).
Results

Effect of Compound K on RAW264.7 Cell Viability
compound K, RAW 264.7 cells were treated with various concentrations of compound K, under concentrations in previous study related with inflammation [18] , and then cell viability was determined using XTT assay. Compound K at concentrations up to 40 μM did not significantly affect RAW264.7 cell viability ( Figure 1B) . It was confirmed by observing cell morphology under a microscope (data not shown). Accordingly, all of the following experiments were performed within this range of compound K concentrations (20, 30 , and 40 μM). 
Inhibitory Effect of Compound K on LPS-Induced NO Production and iNOS and COX-2 Expression Levels
To assess the inhibitory effects of compound K on LPS-induced NO production, RAW 264.7 cells were treated with various concentration of compound K and then incubated with or without LPS (1 µg/mL) for 24 h. As shown in Figure 2A , compound K treatment in LPS-treated RAW 264.7 cells significantly inhibited the production of NO in a dose-dependent manner. From the results of RT-PCR and Western blot analysis, we found that compound K effectively suppressed LPS-induced mRNA and protein expression of iNOS, which is one of key enzymes generating NO from the amino acid L-arginine ( Figure 2B ,D). In addition, compound K suppressed LPS-induced COX-2 mRNA and protein levels ( Figure 2B ,D). Expression of COX-2 and iNOS in mRNA was reduced by 90% and 70%, respectively, and in protein levels was reduced by 68% and 54%, respectively, by 40 µM of compound K ( Figure 2C ,E). These data indicate that compound K effectively inhibited LPS-induced inflammatory responses by suppressing the expression of iNOS and COX-2 in RAW264.7 macrophages.
Inhibitory Effect of Compound K on LPS-Induced IL-1β and IL-6 Release and Their Expressions
To investigate whether compound K could inhibit LPS-induced pro-inflammatory cytokines production, cells were pretreated with compound K for 1 h and then stimulated with LPS (1 µg/mL) for 24 h. From the results of RT-PCR and EIA kit analyses, we found that LPS treatment in RAW 264.7 macrophages enhanced mRNA and release levels of pro-inflammatory cytokines IL-1β and IL-6 compared with those of untreated cells ( Figure 3A ). Our RT-PCR analysis showed that mRNA expression levels of IL-1β and IL-6, which are crucial inflammatory cytokines, were reduced with treatment with compound K ( Figure 3A ). Compound K (40 µM) reduced the mRNA expression levels of IL-1β and IL-6 by 34% and 21%, respectively, compared with the control ( Figure 3B ). In an enzyme immunoassay, release levels of these cytokines IL-6 and IL-1β secreted from LPS-treated macrophages were significantly decreased by compound K treatment in a dose-dependent way ( Figure 3C ). In particular, compound K, at a concentration of 40 µM, effectively inhibited LPS-induced IL-1β release compared with those of the LPS-only control ( Figure 3C ). These results indicate that compound K inhibited LPS-induced pro-inflammatory cytokines production in RAW 264.7 macrophages.
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Inhibitory Effect of Compound K on LPS-Induced IκB Phosphorylation and NF-κB Translocation
To define the molecular action of compound K on the inhibition of inflammatory responses, we examined translocation activity of NF-κB, which is a key transcription factor that controls the many pro-inflammatory cytokines and genes, by analyzing translocation of NF-κB p65 from the cytoplasm into the nucleus using Western blot analysis. We found that the amount of p65, a key subunit of NF-κB, in the nuclear fraction was enhanced by LPS treatment compared with those of untreated control (Figure 4C,D) . Compound K inhibited translocation of p65 in LPS-treated RAW 
To define the molecular action of compound K on the inhibition of inflammatory responses, we examined translocation activity of NF-κB, which is a key transcription factor that controls the many pro-inflammatory cytokines and genes, by analyzing translocation of NF-κB p65 from the cytoplasm into the nucleus using Western blot analysis. We found that the amount of p65, a key subunit of NF-κB, in the nuclear fraction was enhanced by LPS treatment compared with those of untreated control ( Figure 4C,D) . Compound K inhibited translocation of p65 in LPS-treated RAW 264.7 macrophages. In particular, compound K at a concentration of 40 µM remarkably decreased translocation of p65 in the nuclear fraction ( Figure 4C,D) . Translocation of NF-κB into nucleus was known to be related with phosphorylation of IκB-α in TLR4 pathway, which is a major inflammatory pathway. We examined the phosphorylation of IκB-α, a mediator of NF-κB activation. Our data showed that LPS increased phosphorylated IκB-α level, but compound K inhibited phosphorylation of IκB-α compared with those of the LPS control ( Figure 4A,B) . These results indicate that compound K inhibited LPS-induced inflammatory responses by the deactivation of NF-κB and IκB-α. 
Inhibitory Effect of Compound K on LPS-Induced MAPKs Activation
MAPK signaling pathways regulate signal transduction and inflammatory mediators via activation of NF-κB [8] . We investigated whether compound K could inhibit LPS-induced MAPKs signaling. Since MAPK is activated through phosphorylation, we determined the phosphorylated status of JNK, ERK, p38 MAPK in RAW 264.7 macrophages using Western blot analysis. Compared with the control, higher levels of phosphorylation all three MAPKs were observed in cells treated with LPS ( Figure 5A ). Compound K remarkably inhibited LPS-induced phosphorylation of ERK and JNK, but phosphorylation of p38 MAPK in the LPS-treated macrophages was not decreased by compound K treatment ( Figure 5A ). The decrease in phosphorylation of ERK and JNK was 27% and 54%, respectively, by 40 μM Compound K ( Figure 5B ). Our result indicated that inhibition of ERK and JNK rather than p38 contributes to anti-inflammatory effect of compound K in LPS-induced inflammatory response. 
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Inhibitory Effect of Compound K on LPS-Induced NO Productions in Experimental Zebrafish Model
Prior to measure of the NO inhibitory effect of Compound K, we first examined its toxicity on the survival of zebrafish. The embryos of zebrafish were treated with LPS (5 µg/mL) and compound K (40 µM) for 48 h. Compound K and LPS did not affect cytotoxicity on zebrafish (data not shown). Before starting the treatment, we monitored the zebrafish, including the pigmentation, the size, and shape of the yolk structure. Physical changes were not observed with all groups (data not shown). To confirm that compound K has anti-inflammatory activity, we investigate the anti-inflammatory effect of compound K in vivo using the zebrafish model. To show NO production in LPS-stimulated inflammation zebrafish model, we used a fluorescent probe dye, DAF-FM DA. As shown in Figure 6A , the level of NO production in zebrafish was increased by the LPS treatment compared with untreated control. LPS-induced elevation of NO production was significantly reduced with compound K treatment ( Figure 6A ). In particular, 40 µM Compound K inhibited LPS-induced NO production in zebrafish by 30% compared with the LPS control group ( Figure 6B ). Our result showed that compound K effectively reduced LPS-induced NO production in vivo. 
Prior to measure of the NO inhibitory effect of Compound K, we first examined its toxicity on the survival of zebrafish. The embryos of zebrafish were treated with LPS (5 μg/mL) and compound K (40 μM) for 48 h. Compound K and LPS did not affect cytotoxicity on zebrafish (data not shown). Before starting the treatment, we monitored the zebrafish, including the pigmentation, the size, and shape of the yolk structure. Physical changes were not observed with all groups (data not shown). To confirm that compound K has anti-inflammatory activity, we investigate the anti-inflammatory effect of compound K in vivo using the zebrafish model. To show NO production in LPS-stimulated inflammation zebrafish model, we used a fluorescent probe dye, DAF-FM DA. As shown in Figure  6A , the level of NO production in zebrafish was increased by the LPS treatment compared with untreated control. LPS-induced elevation of NO production was significantly reduced with compound K treatment ( Figure 6A ). In particular, 40 μM Compound K inhibited LPS-induced NO production in zebrafish by 30% compared with the LPS control group ( Figure 6B ). Our result showed that compound K effectively reduced LPS-induced NO production in vivo. 
Discussion
We have demonstrated that compound K effectively inhibited the inflammatory response in LPS-treated RAW 264.7 macrophages and zebrafish. Our previous study compared the anti-inflammatory effects of ginsenoside Rb1 and compound K to investigate how the biotransformation of ginsenosides affects their biological activity, and we showed that compound K, rather than Rb1, significantly inhibited the inflammatory response. However, the mechanisms by which compound K is effective against inflammation are unknown. Therefore, in this study we 
We have demonstrated that compound K effectively inhibited the inflammatory response in LPS-treated RAW 264.7 macrophages and zebrafish.
Our previous study compared the anti-inflammatory effects of ginsenoside Rb1 and compound K to investigate how the biotransformation of ginsenosides affects their biological activity, and we showed that compound K, rather than Rb1, significantly inhibited the inflammatory response. However, the mechanisms by which compound K is effective against inflammation are unknown. Therefore, in this study we confirmed the anti-inflammatory effect of compound K in LPS-stimulated Raw 264.7 macrophages and zebrafish models and investigated its molecular signaling pathways. Compound K reduced NO production dose-dependently both in vivo and in vitro. Excessive levels of NO, induced by LPS in macrophages, are associated with inflammatory diseases and are involved in other negative cellular physiologies such as mutagenesis, DNA structural damage, and formation of N-nitrosoamines [29] [30] [31] . Our data provide evidence that compound K reduces LPS-induced NO production dose-dependently and down-regulates iNOS, which is closely related to the synthesis of NO. COX-2, another inflammatory marker, is also associated with the production of pro-inflammatory molecules, such as prostaglandin E2, and promotes pro-inflammatory signaling cascades. Hernandez et al. (2001) reported that COX-2 was stimulated in angiogenesis-related diseases, such as rheumatoid arthritis and psoriasis [32] . In the present study, we reconfirm that compound K effectively suppressed LPS-induced mRNA and protein expression of COX-2 in macrophages. Inflammatory cytokines play important roles in the extent of inflammation and recruit other immune cells implicated in the pathogenesis of inflammatory conditions, such as rheumatoid arthritis and septic shock [33] . IL-1β is an important inflammatory cytokine produced by LPS-activated macrophages. During the inflammatory response, it increased secretion of IL-1β leads to cell or tissue damage. IL-6, a pro-inflammatory cytokine, acts as an endogenous pyrogen in addition to its multiple effects on the immune system and particularly on hematopoiesis [34] [35] [36] . Reduced secretion of IL-1β and IL-6, pro-inflammatory cytokines, from macrophages may retard inflammatory responses to LPS stimulation. In the present study, IL-1β and IL-6 mRNA expression levels were decreased markedly in LPS-treated cells after treatment with compound K. In addition, compound K significantly attenuated the release of pro-inflammatory cytokines in a dose-dependent manner. Therefore, these results indicate that compound K may have an anti-inflammatory effect.
The regulation of inflammatory cytokines and inflammatory responses are regulated transcriptionally by NF-κB transcription factors. Macrophages activated by LPS accelerate IκBα phosphorylation, which leads to its subsequent degradation [37] . After the degradation of IκBα, the activated NF-κB is translocated into the nucleus and binds to NF-κB-binding sites in the promoter regions of inflammatory mediators to induce their transcription, promoting the expression of inflammatory genes, including iNOS, COX-2, and the inflammatory cytokines, IL-6 and IL-1β [38] . In the present study, to evaluate the effect of compound K on NF-κB translocation, we determined the expression levels of phosphorylated IκBα and nuclear and cytosolic p65 by Western blot analysis using anti-NF-κB p65 and IκBα antibodies. Our results showed that compound K suppressed the expression levels of phosphorylated IκBα and inhibited p65 translocation into the nucleus in LPS-treated cells, suggesting that compound K has anti-inflammatory effects via the suppression of IκBα phosphorylation and NF-κB translocation in LPS-stimulated Raw 264.7 cells.
MAPK signaling pathways regulate signal transduction and inflammatory mediators via activation of NF-κB [8] . This kinase family is composed of several members, including JNK, ERK, and p38, and is activated by phosphorylation. We examined the modulation of upstream signaling molecules related to NF-κB inactivation and observed that compound K inhibited the phosphorylation of ERK and JNK, but not p38, in LPS-stimulated macrophages. Taken together, these results indicated that compound K exhibits anti-inflammatory properties by down-regulating NF-κB and MAPK signaling pathways in LPS-stimulated RAW264.7 macrophages.
We used zebrafish as an in vivo model system to confirm the anti-inflammatory effects of compound K. Zebrafish provide a highly informative vertebrate model system for biological research, as they show physiological similarity to mammals but can be examined in large quantities at a low cost, and their transparent body facilitates physiological examinations [39, 40] . Recent studies demonstrated the utility of zebrafish as a model system for drug discovery research [41, 42] . Zebrafish also possess innate and acquired immune systems similar to those of mammals). We selected 7-9 hpf larvae and treated embryo for 25 h with Compound K. Especially, the anti-inflammatory effect of compounds was confirmed at the level of NO production using DAF-FM-DA stained in LPS-stimulated zebrafish [26] . Lepiller et al. demonstrated that DAF-FM DA can be used to monitor changes in NO production in zebrafish. Moreover NO was detected in between 24 and 48 hpf [43] . Our data showed that compound K effectively reduced LPS-induced NO production in zebrafish, thus demonstrating the anti-inflammatory effect of compound K in vivo. To our knowledge, this is the first report demonstrating an anti-inflammatory effect of compound K in an experimental zebrafish model.
Conclusions
In summary, we demonstrated anti-inflammatory properties of compound K using in vitro and in vivo experimental models. Compound K effectively inhibited LPS-induced inflammatory molecules and cytokine production. Further, compound K was shown to inhibit inflammatory responses via suppression of NF-κB and MAPK signaling pathways. Therefore, our study provides important information that can be used towards the development of anti-inflammatory agents containing compound K.
